Terry Mark A, Straiko Michael D, Veldman Peter B, Talajic Julia C, VanZyl Cor, Sales Christopher S, Mayko Zachary M
*Cornea Service, Devers Eye Institute, Portland, OR; and †Lions VisionGift, Portland, OR.
Cornea. 2015 Aug;34(8):845-52. doi: 10.1097/ICO.0000000000000479.
To report low complication rates in Descemet membrane endothelial keratoplasty (DMEK) using sulfur hexafluoride (SF6) gas, a novel glass injector, and donor tissue prestripped by an eye bank technician.
A standardized technique of DMEK was performed in 80 consecutive Fuchs corneal dystrophy cases using technician-prestripped tissue, a novel glass injector, a modified Yoeruek tap technique, and an SF6 gas (20% concentration) bubble for prolonged tissue support. Twenty-five donors were premarked with an "S" stamp for intraoperative orientation. Surgery was performed by 2 experienced DMEK surgeons and 2 inexperienced cornea fellows. Complications were recorded, and the percent endothelial cell loss was calculated at 6 months postoperatively.
There were 5 cases that received an air bubble injection postoperatively (6% rebubble rate). There were 6 grafts that immediately failed, 2 because of excessive surgical trauma, and 4 because of upside-down graft placement documented by optical coherence tomography. None of the 25 cases with an S stamp failed. Recipient corneas cleared quickly with no clinical evidence of toxicity from the SF6 gas bubble, and the grafts experienced a mean endothelial cell loss of 27% at 6 months.
Tissue prestripped by an eye bank technician can be safely used for DMEK surgery. SF6 gas for prolonged tissue support may reduce the rebubble rate in DMEK, with no apparent acute toxic effect. An unrecognized upside-down graft was the primary cause of graft failure in this series. Upside-down grafts may be eliminated by the use of donor tissue premarked by the eye bank with an S orientation stamp.
报告使用六氟化硫(SF6)气体、一种新型玻璃注射器以及由眼库技术人员预先剥离的供体组织进行的Descemet膜内皮角膜移植术(DMEK)的低并发症发生率。
对80例连续的Fuchs角膜营养不良病例采用标准化的DMEK技术,使用技术人员预先剥离的组织、一种新型玻璃注射器、改良的Yoeruek穿刺技术以及SF6气体(浓度为20%)气泡以延长组织支撑。25个供体预先用“S”标记以便术中定位。手术由2名经验丰富的DMEK外科医生和2名经验不足的角膜研究员进行。记录并发症情况,并在术后6个月计算内皮细胞丢失百分比。
有5例术后接受了气泡注射(再气泡率为6%)。有6片移植物立即失败,2例是由于手术创伤过大,4例是由于光学相干断层扫描显示移植物放置颠倒。25例带有“S”标记的病例均未失败。受体角膜迅速清除,没有SF6气泡毒性的临床证据,移植物在6个月时内皮细胞平均丢失27%。
眼库技术人员预先剥离的组织可安全用于DMEK手术。用于延长组织支撑的SF6气体可能会降低DMEK中的再气泡率,且无明显急性毒性作用。本系列中移植物失败的主要原因是未识别出的移植物放置颠倒。使用眼库预先用“S”方向标记的供体组织可消除移植物放置颠倒的情况。